In addition, WHO has asked MOH to found a vaccine institute to deal with global epidemic threats. Given these factors, there is a need for private investment to establish an institute to manufacture essential vaccines, partnering a global manufacturer with a National Champion or experienced technical partners. The partnership will create an integrated mini cluster that comprises R&D, bulk production and formulation-and-fill-and-finish operations.
MOH will support this initiative by acquiring bacterial and viral seeds and cell lines to develop vaccine bulk.
Time:
Profile: Pre-fabricated element manufacturers demonstrating excellent quality and precision.
Initial investment:
Market data
Jobs : 800
No of Projects : 1
Market Size : TBD
To Be Determined
Source: Saudi Arabian General Investment Authority (SAGIA) www.sagia.gov.sa